102 related articles for article (PubMed ID: 2144869)
1. Red blood cell calcium level in chronic renal failure: effect of continuous ambulatory peritoneal dialysis.
Gafter U; Malachi T; Barak H; Levi J
J Lab Clin Med; 1990 Sep; 116(3):386-92. PubMed ID: 2144869
[TBL] [Abstract][Full Text] [Related]
2. Red blood cell calcium homeostasis in patients with end-stage renal disease.
Gafter U; Malachi T; Barak H; Djaldetti M; Levi J
J Lab Clin Med; 1989 Sep; 114(3):222-31. PubMed ID: 2527934
[TBL] [Abstract][Full Text] [Related]
3. Red blood cell calcium level is elevated in women: enhanced calcium influx by estrogens.
Gafter U; Malachi T; Barak H; Levi J
J Lab Clin Med; 1993 Mar; 121(3):486-92. PubMed ID: 8445297
[TBL] [Abstract][Full Text] [Related]
4. Activation of L-arginine transport in undialysed chronic renal failure and continuous ambulatory peritoneal dialysis patients.
Brunini TM; Roberts NB; Yaqoob MM; Ellory JC; Mann GE; Mendes Ribeiro AC
Clin Exp Pharmacol Physiol; 2006; 33(1-2):114-8. PubMed ID: 16445709
[TBL] [Abstract][Full Text] [Related]
5. [Changes in RBC Ca2(+)-ATPase activity and red-cell calcium concentration during dialysis in patients with uremia].
Yang Y
Zhonghua Yi Xue Za Zhi; 1990 Jan; 70(1):23-5, 4. PubMed ID: 2157534
[TBL] [Abstract][Full Text] [Related]
6. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A
Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
[TBL] [Abstract][Full Text] [Related]
7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic enzymes in chronic renal failure.
Royse VL; Jensen DM; Corwin HL
Arch Intern Med; 1987 Mar; 147(3):537-9. PubMed ID: 2435254
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of serum ionized magnesium in patients receiving hemodialysis or peritoneal dialysis.
Markell MS; Altura BT; Sarn Y; Delano BG; Ifudu O; Friedman EA; Altura BM
ASAIO J; 1993; 39(3):M801-4. PubMed ID: 8268649
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
11. Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis.
Ballow A; Gader AM; Huraib S; Mitwalli A; Al-Suleimani F; Al-Wakeel J
Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):177-85. PubMed ID: 17496391
[TBL] [Abstract][Full Text] [Related]
12. Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD).
Yamauchi A; Fujii M; Shirai D; Mikami H; Okada A; Imai E; Ando A; Orita Y; Kamada T
Clin Nephrol; 1986 Apr; 25(4):181-5. PubMed ID: 3698351
[TBL] [Abstract][Full Text] [Related]
13. High-performance liquid chromatographic characterization of neurophysins in chronic renal failure.
Amico JA; Silver MR; Finn FM; Robinson AG
J Lab Clin Med; 1987 Oct; 110(4):439-47. PubMed ID: 3655523
[TBL] [Abstract][Full Text] [Related]
14. Influenza antibody titers after vaccination of chronic renal failure patients; before and during hemodialysis, or on continuous ambulatory peritoneal dialysis.
Suga T; Niki H; Niikura M; Matsumoto Y; Nishimura T; Nakajima K; Miyazaki M; Endoh M; Nomoto Y; Sakai H
Tokai J Exp Clin Med; 1990 May; 15(2-3):245-51. PubMed ID: 2130531
[TBL] [Abstract][Full Text] [Related]
15. Cell cholesterol transport to plasma in blood from patients with renal failure or a kidney transplant.
Sutherland WH; Corboy J; Walker RJ; Robertson MC; Ball MJ
Nephrol Dial Transplant; 1995; 10(3):358-65. PubMed ID: 7792031
[TBL] [Abstract][Full Text] [Related]
16. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
[TBL] [Abstract][Full Text] [Related]
17. Alleviation of sleep apnea in patients with chronic renal failure by nocturnal cycler-assisted peritoneal dialysis compared with conventional continuous ambulatory peritoneal dialysis.
Tang SC; Lam B; Ku PP; Leung WS; Chu CM; Ho YW; Ip MS; Lai KN
J Am Soc Nephrol; 2006 Sep; 17(9):2607-16. PubMed ID: 16885414
[TBL] [Abstract][Full Text] [Related]
18. Plasma calcitonin concentration in patients treated with chronic dialysis: differences between hemodialysis and CAPD.
Martínez ME; Miguel JL; Gómez P; Selgas R; Salinas M; Gentil M; Mateos F; Montero JL; Sánchez Sicilia L
Clin Nephrol; 1983 May; 19(5):250-3. PubMed ID: 6851265
[TBL] [Abstract][Full Text] [Related]
19. Systemic and intraperitoneal proinflammatory cytokine profiles in patients on continuous ambulatory peritoneal dialysis.
Maksic D; Vasilijic S; Colic M; Stankovic-Popovic V; Bokonjic D
Adv Perit Dial; 2009; 25():50-5. PubMed ID: 19886317
[TBL] [Abstract][Full Text] [Related]
20. Behavior of beta 2-microglobulin in patients with chronic renal failure undergoing hemodialysis, hemodiafiltration and continuous ambulatory peritoneal dialysis (CAPD).
Blumberg A; Bürgi W
Clin Nephrol; 1987 May; 27(5):245-9. PubMed ID: 3297439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
